123 related articles for article (PubMed ID: 37084489)
1. LPA receptor-mediated signaling regulates cell motility and survival to anticancer drug of pancreatic cancer cells under glucose-deprived and hypoxic conditions.
Takai M; Takauchi M; Kuribayashi M; Tsujiuchi T
Biochem Biophys Res Commun; 2023 Jun; 661():21-27. PubMed ID: 37084489
[TBL] [Abstract][Full Text] [Related]
2. Effects of LPA receptor-mediated signaling on the modulation of cellular functions of pancreatic cancer cells cultured in fibroblast supernatants under hypoxic conditions.
Takai M; Okuda A; Amano Y; Yashiro N; Hara K; Yamamoto M; Tsujiuchi T
J Bioenerg Biomembr; 2023 Jun; 55(3):169-177. PubMed ID: 37219648
[TBL] [Abstract][Full Text] [Related]
3. Lysophosphatidic acid signaling via LPA
Fukushima K; Takahashi K; Yamasaki E; Onishi Y; Fukushima N; Honoki K; Tsujiuchi T
Exp Cell Res; 2017 Mar; 352(1):139-145. PubMed ID: 28189636
[TBL] [Abstract][Full Text] [Related]
4. Roles of lysophosphatidic acid (LPA) receptor-2 (LPA
Okuda A; Takai M; Kurisu R; Takamoto M; Ikeda H; Tsujiuchi T
Int J Radiat Biol; 2023; 99(12):1925-1933. PubMed ID: 37523658
[TBL] [Abstract][Full Text] [Related]
5. Effects of lysophosphatidic acid (LPA) receptor-2 (LPA
Ueda N; Minami K; Ishimoto K; Tsujiuchi T
Cell Signal; 2020 May; 69():109551. PubMed ID: 32006610
[TBL] [Abstract][Full Text] [Related]
6. LPA signaling through LPA receptors regulates cellular functions of endothelial cells treated with anticancer drugs.
Mori S; Araki M; Ishii S; Hirane M; Fukushima K; Tomimatsu A; Takahashi K; Fukushima N; Tsujiuchi T
Mol Cell Biochem; 2015 Oct; 408(1-2):147-54. PubMed ID: 26116018
[TBL] [Abstract][Full Text] [Related]
7. Regulation of cellular responses to X-ray irradiation through the activation of lysophosphatidic acid (LPA) receptor-3 (LPA
Ikeda H; Takai M; Yashiro N; Amano Y; Hara K; Yamamoto M; Tsujiuchi T
Pathol Res Pract; 2024 May; 257():155293. PubMed ID: 38615508
[TBL] [Abstract][Full Text] [Related]
8. Involvement of LPA signaling via LPA receptor-2 in the promotion of malignant properties in osteosarcoma cells.
Takahashi K; Fukushima K; Tanaka K; Minami K; Ishimoto K; Otagaki S; Fukushima N; Honoki K; Tsujiuchi T
Exp Cell Res; 2018 Aug; 369(2):316-324. PubMed ID: 29859140
[TBL] [Abstract][Full Text] [Related]
9. Lysophosphatidic acid (LPA) receptor-mediated signaling regulates hypoxia-induced biological functions of lymphatic endothelial cells.
Yamamoto M; Takai M; Yashiro N; Hayasaka H; Tsujiuchi T
Biochem Biophys Res Commun; 2024 Jun; 715():149982. PubMed ID: 38676998
[TBL] [Abstract][Full Text] [Related]
10. Induction of lysophosphatidic acid (LPA) receptor-mediated signaling regulates cell motility and survival to anticancer drugs in cancer cells treated with hydrogen peroxide.
Takai M; Takamoto M; Amano Y; Yamamoto M; Hara K; Yashiro N; Tsujiuchi T
Adv Biol Regul; 2023 Aug; 89():100978. PubMed ID: 37603941
[TBL] [Abstract][Full Text] [Related]
11. Modulation of chemoresistance by lysophosphatidic acid (LPA) signaling through LPA
Minami K; Ueda N; Maeda H; Ishimoto K; Otagaki S; Tsujiuchi T
Biochem Biophys Res Commun; 2019 Sep; 517(2):359-363. PubMed ID: 31362892
[TBL] [Abstract][Full Text] [Related]
12. Lysophosphatidic acid receptor-2 (LPA
Minami K; Ueda N; Ishimoto K; Tsujiuchi T
Mol Cell Biochem; 2020 Jun; 469(1-2):89-95. PubMed ID: 32301060
[TBL] [Abstract][Full Text] [Related]
13. Effects of lysophosphatidic acid (LPA) signaling via LPA receptors on cellular functions associated with ATP reduction in osteosarcoma cells treated with ethidium bromide.
Kurisu R; Takamoto M; Minami K; Ueda N; Yamada M; Shima N; Otani T; Sakai Y; Kondo D; Tsujiuchi T
J Bioenerg Biomembr; 2022 Apr; 54(2):109-117. PubMed ID: 35260987
[TBL] [Abstract][Full Text] [Related]
14. Enhanced cellular functions through induction of LPA
Takahashi K; Fukushima K; Fukushima N; Honoki K; Tsujiuchi T
Mol Cell Biochem; 2017 Jul; 431(1-2):29-35. PubMed ID: 28205098
[TBL] [Abstract][Full Text] [Related]
15. Roles of endothelial cells in the regulation of cell motility via lysophosphatidic acid receptor-2 (LPA
Minami K; Ueda N; Ishimoto K; Kurisu R; Takamoto M; Ikeda H; Tsujiuchi T
Exp Mol Pathol; 2021 Feb; 118():104596. PubMed ID: 33347862
[TBL] [Abstract][Full Text] [Related]
16. Opposite roles of LPA1 and LPA3 on cell motile and invasive activities of pancreatic cancer cells.
Kato K; Yoshikawa K; Tanabe E; Kitayoshi M; Fukui R; Fukushima N; Tsujiuchi T
Tumour Biol; 2012 Oct; 33(5):1739-44. PubMed ID: 22678979
[TBL] [Abstract][Full Text] [Related]
17. Cooperation of G12/13 and Gi proteins via lysophosphatidic acid receptor-2 (LPA
Minami K; Ueda N; Ishimoto K; Kurisu R; Takamoto M; Ikeda H; Tsujiuchi T
Biochem Biophys Res Commun; 2020 Nov; 532(3):427-432. PubMed ID: 32883524
[TBL] [Abstract][Full Text] [Related]
18. LPA
Minami K; Ueda N; Ishimoto K; Tsujiuchi T
Exp Cell Res; 2020 Mar; 388(1):111813. PubMed ID: 31904382
[TBL] [Abstract][Full Text] [Related]
19. Lysophosphatidic acid stimulates activation of focal adhesion kinase and paxillin and promotes cell motility, via LPA1-3, in human pancreatic cancer.
Liao Y; Mu G; Zhang L; Zhou W; Zhang J; Yu H
Dig Dis Sci; 2013 Dec; 58(12):3524-33. PubMed ID: 24061591
[TBL] [Abstract][Full Text] [Related]
20. Roles of lysophosphatidic acid (LPA) receptor-mediated signaling in cellular functions modulated by endothelial cells in pancreatic cancer cells under hypoxic conditions.
Takai M; Yashiro N; Hara K; Amano Y; Yamamoto M; Tsujiuchi T
Pathol Res Pract; 2024 Mar; 255():155192. PubMed ID: 38367602
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
